Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.08, $0.27 better than the analyst estimate of $4.81. Revenue for the quarter came in at $10.68 billion versus the consensus estimate of $9.92 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.